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ABSTRACT 
Objective: The aim of the present study was to fabricate and evaluate the drug release studies using Sodium Alginate (SA) and Gelatin (GE) 
microbeads intercalated with Kaolin (KA) nanoclay for sustained release of D-Penicillamine (D-PA). 
Methods: Sodium alginate/gelatin/Kaolin blend microbeads were prepared by an extrusion method by using glutaraldehyde (GA) as a crosslinker. 
The obtained microbeads were characterized by Fourier transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM) and X–ray 
diffraction (XRD). Drug release kinetics of the microbeads was investigated in simulated intestinal fluid (pH 7.4) at 37 °C.  
Results: Microbeads formation was confirmed by FTIR spectroscopy. X-RD reveals that the KA should be intercalated with the drug and also it confirms 
the molecular level dispersion of D-Penicillamine into microbeads. Scanning Electron Microscopy (SEM) studies reveal that the beads were in spherical 
shape with some wrinkled depressions on the surface. The in vitro release study indicates the D-Penicillamine released in a controlled manner. The in 
vitro release kinetics was assessed by Korsmeyer-Peppas equation and the ‘n’ value lies in between 0.557-0.693 indicates Non-Fickian diffusion process. 
Conclusion: The results suggest that the developed KA intercalated microbeads are good potential drug carrier for the controlled release of D-PA. 
Keywords: Sodium alginate (SA), Gelatin (GE), Kaolin (KA), Drug delivery, D-Penicillamine (D-PA) 




In the last two decades, researchers have shown much interest in the 
use of nanoclay materials, most notably Kaolinite [1, 2], 
montmorillonite [3-5], diatomic [6-8], palygorskite [9], and halloysite 
[10-12], especially in biomedical field. This interest is largely stems 
from the human interest due to its biocompatibility, biostability, 
degradability, non-toxic and increase the drug efficiency in drug 
delivery systems [13].  
Kaolin, Al2Si2O5 (OH)4 (KA) is a two-dimensional (2D) natural 
aluminosilicate mineral which has been used in the field of biomedical 
applications for centuries [14]. In fact their medicinal utilities have 
been discovered by many traditional civilizations (Egyptians, 
Assyrians, Babylonians, Indians, Chinese), Greeks, Romans and 
medieval Arab Muslims till the recent times [15]. Kaolinite is used in 
the treatment of colitis, enteritis, dysentery and diarrhoea [16]. In the 
last few decades, researchers have paid huge attention to use KA 
minerals, because it can acts as active excipient in solid and semisolid 
pharmaceutical dosage forms and control the efficiency of the dosage 
forms which can improve the drug bioavailability [17-19]. 
Sodium Alginate (SA) is an anionic biodegradable natural polymer 
with 1,4-β-d-mannuronic acid (M block) and α-l-guluronic acid (G- 
block) residues [20]. The polymer forms a three-dimensional hydrogel 
which network due to the interaction between the carboxylic acid 
group (Gblock) and divalent counter ion (e. g Ca2+, Mg2+and Zn2+) and 
makes egg-box structure, results a cross linked hydrogels is useful in 
controlled release of bioactive molecules [21, 22]. SA crosslinked 
calcium beads could protect the acid sensitive drugs from gastric juice 
and consequently released from the beads in the intestine [23]. F. 
Martínez-Gómez et al., [24] reported that sodium alginate/polyvinyl 
alcohol hydrogels may be appropriate for use in the controlled release 
of drugs in the intestinal tract.  
Gelatin (GE) is a natural protein material obtained by hydrolytic 
degradation of naturally occurring tropocollagen rod (a triple helical 
structure) which is a fundamental molecular unit of collagen [25, 26]. 
In the recent decades it has been used in food and pharmaceutical 
industries due to its non-toxic, anti-carcinogenic, biocompatible, 
biodegradable, and also attractive starting material as a drug carrier 
due to its unique gelling properties [27]. Phadke et al., [28] reported 
that it was somewhat difficult to prepare long-lasting drug delivery 
vehicle because at body temperature it was dissolved very rapidly, 
makes a burst release of drug. In order to overcome these problems 
many researchers have prepared GE networks by crosslinking 
(Glutaraldehyde, formaldehyde and genipin), grafting and coating with 
other polymers. A. P. Rokhade et al., [29] reported that gelatin and 
NaCMC semi IPN microspheres for the effective encapsulation and 
controlled release of ketorolac tromethamine. Pal et al., [30] reported 
that gelatin-g-PAA nanoparticles are fairly suitable and function well 
as swelling controlled drug delivery system. 
D-Penicillamine (D-PA) (fig. 1) is a biologically active aminothiol 
[31], which is used in the treatment of Wilson’s disease and remove 
the excess of copper from the body, may be in the form of deep 
purple colour complex with D-PA by chelation process [32]. D-P is a 
potentially an effective chelator for some transition metals, hence it 
is used as a good choice for treatment of heavy metal poising [33].  
A few articles have been reported the combination of SA and GE for 
controlled drug delivery [34-37], but as per best of our knowledge, 
the use of SA/GE/KA microbeads for controlled release of D-PA has 
not yet been investigated. In this research paper KA intercalated 
SA/GE microbeads were prepared. The developed beads were 
characterized by FTIR, SEM, EDS and X-RD. The dissolution 
experiments were performed to study the drug release 









Fig. 1: Structure of D-penicillamine 
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MATERIALS AND METsHODS 
Materials 
Gelatin and kaolin were purchased from Sigma–Aldrich (USA). 
Sodium alginate, Calcium chloride and Glutaraldehyde (GA) were 
purchased from Sd. Fine chemicals, Mumbai, India. D-Penicillamine a 
gift sample from Suven Life Sciences Ltd., Hyderabad. Water used 
was of high purity grade after double distillation. 
Preparation procedure 
Preparation of SA/GE microbeads 
D-PA loaded microbeads were prepared by simple ionotropic 
gelation method [25]. Briefly, 3% aqueous dispersion of SA and GE 
were prepared separately using double distilled water. Solutions of 
GE and SA were combined in different ratios (table 1). To this drug 
solution was added and stirred for 2hr by using a magnetic stirrer to 
get homogeneous solution. The above mixed solution was 
transferred drop wise into CaCl2 solution, the spherical beads 
formed instantly were kept for 5 min-and then transferred into 2% 
glutaraldehyde solution for crosslinking for 2 h. The obtained wet 
beads were collected by decantation, washed three times with 
distilled water to remove the drug attached on the bead surface, and 
finally were dried in air overnight and then vacuum-dried to 
constant weight at 40 °C.  
Preparation of SA/GE-kaolin nanoclay microbeads 
SA/GE blend solution was prepared by using above procedure. To 
this solution drug and nano kaolin clay was added in different ratios 
(table 1) and stirred for 2hr using magnetic stirrer. This solution 
was placed in sonication for 30 min to get homogeneous solution. 
Then the solution was transferred drop wise into CaCl2 solution, the 
spherical microbeads formed instantly were kept for 5 min and then 
transferred into 2% glutaraldehyde solution for crosslinking for 2 h. 
The obtained wet beads were collected by decantation, washed 
three times with distilled water to remove the drug attached on the 
bead surface, and finally were dried in air overnight and then 
vacuum-dried to constant weight at 40 °C. 
 
Table 1: Formulation, composition and % Encapsulation Efficiency (%EE) of all samples 
Formulation SA (% w/w) GE (% w/w) GA (%) Kaolin (mg) Drug (mg) % EE±SD 
F1 50 50 2 0 50 52.1±1.6 
F2 50 50 2 0 100 54.8±1.9 
F3 50 50 2 0 150 55.1±2.3 
F4 70 30 2 0 100 60.3±1.5 
F5 90 10 2 0 100 64.7±2.0 
F6 90 10 4.0 0 100 62.3±1.8 
F7 90 10 6.0 0 100 60.9±1.5 
F8 90 10 2 800 150 76.3±1.9 
F9 90 10 2 600 150 74.1±1.3 
F10 90 10 2 400 150 71.3±1.6 
F11 90 10 2 200 00 000 
F12 90 10 2 0 00 000 




To determine the optimal time required for maximum intercalation of D-
PA with KA. A known amount of D-PA (30 mg) and KA (100 mg) were 
mixed into 30 ml of double distilled water with continuous stirring at 37 
°C. At regular intervals of time (0.5, 1, 2, 4, 8 and 14 h) the reaction 
mixture was filtered and concentration of D-PA was analyzed using UV 
spectrophotometer at fixed λ-max value of 215.2 nm. 
Effect of pH 
The experiments were performed to estimate the most favourable pH for 
the intercalation of D-PA with KA. For this purpose, a known amount of 
D-PA (30 mg) and KA (100 mg) were dissolved into 30 ml of different pH 
solutions (2.0, 4.6, 6.0, 7.4, 8.5 and 10.5) and stirred at 300rpm for 1 h at 
37 °C. The solution was then filtered and concentration of D-PA in the 
filtrate was analyzed by ultraviolet (UV) spectrophotometer (LabIndia, 
Mumbai, India) at the λ-max of 215.2 nm.  
Fourier transform infrared (FTIR) spectral analysis  
FTIR (Bomem MB-3000 Make: Canada) with Horizon MBTM FTIR 
software was used to record the spectrum of pure SA, pure GE, pristine 
drug, placebo SA/GE microbeads, drug loaded SA/GE microbeads and 
drug loaded SA/GE/KA microbeads to find out the possible chemical 
interactions between polymer matrix, kaolin and drug. The finely 
powdered and dried samples (5 mg) were mixed with 100 mg of KBr in a 
pestle and mortar. Pellets were prepared under a hydraulic pressure of 
600 kg/cm2. These pellets were again crushed and repelleted. This step 
was repeated 2-3 times to get better reproducibility. Spectra were taken 
in the wavelength range 400-4000 cm-1. 
XG-ray diffraction (XRD) analysis 
The XG-ray diffraction of the of pristine drug, SA/GE placebo micro 
beads, drug loaded SA/GE micro beads, SA/GE/KA placebo micro 
beads and drug loaded SA/GE/KA micro beads were performed by a 
wide angle XG-ray scattering diffractometer (Panalytical XG-ray 
Diffractometer, model-X’pert Pro) with CuKα radiation (λ= 1.54060) 
at a scanning rate of 5 °/min to determine the crystallinity. 
Field emission scanning electron microscopy (FESEM) analysis 
The morphological characterization of the microbeads was studied 
by using FESEM (Make: JEOL, Singapore. Model: JEOL JSM-7100F) 
with an accelerating voltage of 20 kV equipped with an EDAX 
detector. 
Determination of encapsulation efficiency 
Percentage of encapsulation efficiency was estimated according to the 
formula and method reported in previous literature [38]. A known 
mass of beads (10 mg) were immersed into 100 ml of phosphate 
buffer solution (pH 7.4 containing 5% absolute ethyl alcohol) for 24 h 
and then crushed the beads to ensure the complete extraction of D-PA 
from the beads. The absorbance of the clear supernatant buffer 
solution containing the extracted amount of D-PA was measured by 
UV–Vis spectrophotometer (LabIndia, Mumbai, India) at the λ-max 
value of 215.2 nm for D-PA with pH 7.4 buffer solution as a blank. 
Concentration of drug was determined by using calibration curve 
constructed by series of D-PA standard solutions. Percentage of 
encapsulation efficiency was calculated by the following equations. 
Drug loading (%) = Weight of drug in microbeads
weight of microbeads
 X 100 
EE (%) = Actual drug loading
Theortical drug loading
 X 100 
In vitro drug release studies 
To study the in vitro drug release kinetics of different formulations 
were performed at 37 °C using a dissolution tester (Lab India, 
Mumbai, India) containing of eight baskets. Accurate quantity of 
dried beads (100 mg) was immersed into 900 ml of phosphate 
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buffer solution pH7.4 at 50 rpm to replicate intestinal fluid 
atmosphere. At a predetermined time intervals 5 ml of sample 
withdrawn and 5 ml of fresh Phosphate buffer solution (PBS) was 
added back to basket to keep total volume constant throughout the 
experiment. Amount of D-PA released was assayed by using a UV–
Vis spectrophotometer at 215.2 nm, and the released drug amount 
was obtained by using concentration versus absorbance calibration 
curve. 
Drug release kinetics 
The drug release kinetics was analyzed by fitting the data in to 
kinetic models, which include zeroth, first order, Higuchi and 
Korsmeyer-peppas [39-42]. Based on the goodness of data fit, the 
highest correlation coefficient was indicative of best-fit model to 
describe drug release kinetics [43]. 
RESULTS AND DISCUSSION 
Intercalation kinetics 
Intercalation kinetics reveals that the time required for intercalation 
of D-PA with KA by a rapid ion-exchange process between sodium 
ions of KA and cations of D-PA molecules. From fig. 2 it was clear 
that 14.9% of D-PA was intercalated in interlayer of KA within 90 
min, and remains constant up to 14h. Therefore we should keep 90 
min time for interaction between D-PA and KA to avoid partial 
interaction in the following experiments. 
 
 
Fig. 2: Effect of time for Intercalation of D-PA with KA 
 
 
Fig. 3: Effect of pH on intercalation of D-PA into KA 
 
Effect of pH 
The effect of pH on the intercalation of D-PA into the interlayer of KA 
is displayed in fig. 3. The results reveal that suitable pH range for 
intercalation of D-PA with KA is 6.0–8.5, because at this range 
intercalation of D-PA almost linear. At pH below 6.0 there was a 
decrease in intercalation of D-PA in KA layer. At a low pH, 
hydronium ions increase, therefore a competition was arise between 
drug molecules and H+ ions of KA layer, thus the system is 
flocculated; hence, adsorption decreases [44].  
Fourier transform infrared (FTIR) spectral analysis 
FTIR spectra of sodium alginate (a), gelatin (b), placebo SA/GE 
microbeads (c), pure drug (d) and drug loaded SA/GE microbeads are 
displayed in fig. 4. FTIR spectra of SA (fig. 4. a) shows a characteristic 
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peaks at 3415 cm-1 corresponds to O-H stretching frequency, the peaks 
arises at 1386 cm-1 and 1594 cm-1 assigned to asymmetric and 
symmetric stretching frequency of carboxylate group C-O. FTIR 
spectra of GE (fig. 4. b) a broad band at 3341 cm-1 corresponded to 
stretching vibration of N–H group, whereas amide (C = O) stretching 
vibrations are observed at 1616 cm-1. Further, the absorption band at 
1373 cm-1 assigned to stretching vibrations of C–N bond. FTIR spectra 
of placebo microbeads (fig. 4. c) a new band formed at 1612 cm-1 is 
assigned to C=N stretching vibrations which indicates the interaction 
between-OH group of SA and NH2 group of GE which confirms the 
formation of microbeads [36]. The FTIR spectra of pristine D-PA (fig. 4. 
d) shows a band at 3473, 2607 and 1627 cm-1 were due to-N–H,-S–H 
and–COOH stretching vibrations. Comparing the FTIR spectra of 
placebo microbeads and drug loaded microbeads, in placebo 
microbeads (fig. 4. c) a band appears at 1612 cm-1, whereas this band 
was shifted to lower wavelength i.e. 1596 cm-1 in drug loaded 
microbeads (fig. 4. e), which indicates the interaction occurs between 
polymer and drug molecule. The band at 2358 cm-1 further indicates 
the presence of S-H stretching frequency, which confirms the drug 
present in the drug loaded microbeads [38]. 
 
 
Fig. 4: FTIR spectra of sodium alginate (a), gelatin (b), placebo SA//GE microbeads (c), pure D-PA (d) and drug loaded SA/GE microbeads (e) 
 
 
Fig. 5: FTIR spectra of SA/GE placebo microbeads (a), drug loaded SA/GE microbeads (b), Pure Kaolin (c) and drug loaded SA/GE/KA 
microbeads (d) 
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Fig. 6: Powder XRD patterns of pristine D-PA (a), SA/GE placebo micro beads (b), drug loaded SA/GE micro beads (c), SA/GE/KA placebo 
micro beads (d) and drug loaded SA/GE/KA micro beads (e) 
 
 
Fig. 7: FESEM images of SA/GE placebo micro beads (a,d), drug loaded SA/GE micro beads (b,e) and drug loaded SA/GE/KA micro beads 
(c,f) and EDS analysis of SA/GE placebo micro beads (g), drug loaded SA/GE micro beads (h) and drug loaded SA/GE/KA micro beads (i) 
 
The FTIR spectrum of KA (fig. 5. c) shows distinct peaks at 3688 
cm-1and 3625 cm-1(O–H stretching frequency of Si–OH and Al–
Al–OH), 3456 cm-1 (H–O–H stretching frequency of interlayer 
water), 1126 and 902 cm-1 corresponds to (Si–O–Si) stretching 
band. Comparing the FTIR spectra of KA and drug loaded 
SA/GE/KA microbeads (fig. 5. d), the intensity of KA peaks in 
drug loaded SA/GE/KA microbeads were weakened and new 
characteristic peaks appeared in drug loaded SA/GE/KA 
microbeads, this is due to intercalation between KA and active 
sites of polymer matrices and drug molecules. This confirms the 
KA intercalates with active sites of polymer matrices and drug 
molecules [13].  
Reddy et al. 




X-ray diffraction (XRD) analysis 
Powder XRD patterns of pristine drug (a), SA/GE placebo micro 
beads (b), drug loaded SA/GE micro beads (c), SA/GE/KA placebo 
micro beads (d) and drug loaded SA/GE/KA micro beads (e) were 
displayed in fig. 8. The XRD pattern of D-PA (fig. 6. a) shows a 
characteristic peaks at 2θ of 9.10 °, 17.04 °, 17.64 °, and 30.18 °, 
represents the crystalline nature. Whereas the crystalline peaks are 
not completely observed in drug loaded SA/GE micro beads (fig. 6. 
c), this suggests that the drug is dispersed at molecular level in the 
polymer matrix. The XRD patterns of SA/GE/KA placebo micro 
beads (fig. 6. d) shows a characteristic peaks at 11.98 ° and 20.06 °, 
indicates KA is present in the microbeads. Whereas these peaks 
were observed in the drug loaded SA/GE/KA micro beads (fig. 6. e) 
but the basal space of these peaks were increased this indicates the 
KA intercalates with the drug molecules. 
FESEM and EDS analysis 
In order to examine the surface morphology and chemical composition 
of KA loaded SA/PEG microbeads, surface SEM image and EDS analysis 
were performed. Fig. 7 presents the topographical images of placebo 
SA/GE microbeads (fig. 7. a and d), drug loaded SA/GE microbeads (fig. 
7. b and e) and drug loaded SA/GE/KA microbeads (fig. 7. c and f). The 
SEM image of placebo SA/GE microbeads shows spherical, uniform 
and smooth surface with detectable pores. Whereas the drug loaded 
SA/GE microbeads shows pores on the surface this indicates drug 
should be loaded in the beads. The SEM image of drug loaded 
SA/GE/KA microbeads shows higher roughness compared with the 
drug loaded microbeads this is due to the hydrophilic character of clay 
which facilitates the miscibility of KA with SA/PEG blend matrix. 
Higher the KA contents in the polymer matrix higher the surface 
roughness in the microbeads. This is due to polymer matrix molecules 
that migrate toward the negative charge of the clay and entered into 
the clay layers and finally form a porous structure. This confirms the 
kaolin loaded in the microbeads [45].  
The energy-dispersive X-ray spectra (EDS) analysis shows the 
presence of C, N, O elements in the placebo SA/GE microbeads (fig. 7. 
g) and drug loaded SA/GE/KA microbeads (fig. 7. h). On comparing 
the EDS spectra of placebo SA/GE microbeads and drug loaded 
SA/GE/KA microbeads in both spectra nitrogen peaks were 
observed indicating the presence of gelatin polymer. But the 
nitrogen peak in drug loaded SA/GE/KA microbeads is more intense 
than the peak present in placebo SA/GE microbeads and also 
additional Sulphur peak was observed in drug loaded SA/GE 
microbeads, which confirms the drug present in drug loaded SA/GE 
microbeads. Whereas the additional signals corresponding to the Si 
and Al elements were detected in the drug SA/GE/KA microbeads 
(fig. 7. i). This confirms the KA present in the microbeads. 
Determination of % encapsulation efficiency (%EE) 
The percentages of encapsulation efficiency (%EE) of D-PA loaded 
microbeads are displayed in table 1. The values are (%EE) lies in 
between 52.1% to 76.3%. This indicates the %EE dependence on 
formulation parameters which include percentage of blend 
composition, concentration of GA and KA. The percentage of EE in 
formulations of F1, F2 and F3 decreases with the increase of gelatin 
composition in the blend composition, the decrease of encapsulation 
is due to gelatin might have assisted the diffusion of drug particles 
into the external surface to form pores in the matrix. As the 
concentration of glutaraldehyde increases in the formulations of F5, 
F6 and F7 the %EE decreases, this is due to the crosslinking density 
increases the microbeads will become more rigid, thereby the cross-
linker reduced the sizes of voids in the matrix. The formulations 
F8,F9,F10 with the increasing the amount of KA in the polymer 
matrix, the percentage of D-PA encapsulation efficiency increased 
this is due to kaolin has large specific area in its structure, good 
absorption capacity and develops hydrogen bonding between D-PA 
and hydroxyl groups present on surface of KA.  
In vitro drug release studies 
Based on the results of effect of pH on intercalation of clay and drug, 
the cumulative percentage of drug release was studied for all the 
formulations in pH 7.4 buffer solution at 37 °C. In vitro drug release 
studies were discussed in terms of effect of polymer, effect of kaolin 
clay, drug variation and crosslinker variation. 
Effect of polymer variation 
The effect of polymer blend content was studied with constant loading 
of D-PA and glutaraldehyde. The drug release profiles of F2, F4 and F5 
are 80.4%, 87% and 92% respectively are displayed in fig. 8. This 
suggests that drug release rate increases with increasing content of 
sodium alginate, this is due to hydrophilic nature of sodium alginate 
[46], whereas the gelatin concentration increases the drug release rate 
decreases, this is due to the rigid nature of SA/GE blend component 
and the possible hydrogen-bonding interactions between −COO− of 
sodium alginate and N–H group of gelatin. 
 
 
Fig. 8: Effect of polymer variation on in vitro release profiles for formulations F2 (50:50 ratioof SA: GE), F4 (70:30 ratio of SA: GE) and F5 
(90:10 ratio of SA: GE) at pH7.4 
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Effect of crosslinking agent 
To investigate the effect of crosslinker on in vitro release profiles 
was studied by plotting the cumulative % of drug release data 
against time for varying concentration of GA (i.e., 2.0, 4.0 and 6.0 ml) 
with constant of D-PA and polymer blend matrix are displayed in fig. 
9. The drug release rate was higher when the microbeads containing 
small concentration of GA (i.e., 2 ml), whereas the release rate was 
lower when GA concentration was increased (i.e., 6 ml) in the 
polymer matrix. This is due to increased stiffness in polymer chains 
and reduced porosity of microbeads at higher crosslink densities, 
thereby hindering the transport of D-PA through the microbeads. 
 
 
Fig. 9: Effect of crosslinker on in vitro release profiles for formulations F5 (2 ml), F6 (4 ml) and F7 (6 ml) at pH7.4 
 
Effect of drug loading 
Fig. 10 shows the effect of drug variation on in vitro release profiles 
was studied at a constant amount of polymer blend composition and 
crosslinker. The amount of drug loaded in the formulations F1, F2 
and F3 are 50, 100 and 150 mg respectively. The % of cumulative 
drug release for F1, F2 and F3 are 77%, 80% and 83% respectively. 
The release profile shows a burst release with in 2 h and extended 
the release over the remaining time is due to swelling of the 
hydrophilic matrix. From the cumulative release data, it was found 
that the formulation which contains more amount of drug (F3) 
showed higher release rates and the formulation which contains 
lower amount of drug (F1) showed lower release rate. This indicates 
that release rates vary depending on the amount of drug in the 
matrices, i.e., the release rate was found to be significantly faster at 
higher amounts of drug this is due to osmotic pressure is high in 
higher concentration of drug which leads to quick diffusion of drug 
from the matrix to dissolution media [47]. The release rate was 
slower in F1, this might be due to the availability of extra free void 
spaces through which fewer drug molecules will transport [48]. 
 
 
Fig. 10: Effect of % drug loading on in vitro release profiles for formulations F1 (50 mg), F2 (100 mg), and F3 (150 mg) 
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Effect of kaolin clay 
To understand the effect of KA on in vitro release profiles was 
studied by plot the cumulative % of drug release data against time 
for varying amounts of KA (i.e., 400, 600 and 800 mg) with constant 
D-PA and polymer blend matrix are displayed in fig. 11. The 
cumulative release rate of D-PA from microbeads containing KA is 
decreases as the concentration of KA increases, this is due to 
intercalated drug cannot be exchanged completely in ion exchange 
process with phosphate ions of the buffer solution and also the 
electrostatic attraction between amino groups of D-PA and anionic 
groups of KA layer which leads to incomplete release process.
 
 
Fig. 11: Effect of kaolin nano clay variation on in vitro release profiles for formulations F8 (800 mg), F9 (600 mg) and F10 (400 mg) 
  
Drug release kinetics 
To find out the drug release mechanism, the data obtained from in 
vitro drug release studies in PBS (7.4) were fitted into different 
kinetic models including zero order, first order, Higuchi and 
Korsmeyer-Peppas models which are empirical in nature, the results 
of rate constant and correlation coefficient (r2) of all formulations 
are displayed in table 2. The correlation coefficient values indicated 
that drug release kinetics neither follow zero order nor first order. 
The r2 values were close to Higuchi and Korsmeyer peppas models. 
Therefore the drug release kinetics follows Higuchi model. 
According to Higuchi model the drug release from the microbeads, 
involves the penetration of liquid into the matrix and dissolves the 
drug, which then diffuses the drug into the exterior liquid through 
pores or intestinal channels. According to the principles of Higuchi 
and Korsmeyer-Peppas models it was clear that it the drug release 
process involves the simple diffusion phenomenon. Further, the type 
of diffusion was revealed by Korsmeyer-Peppas model. The first 
60% drug release data were fitted into Korsmeyer-Peppas model.  
Mt
M∝
 = ktn 
Where, Mt/Mα represents the fractional drug release at time t, k is a 
constant characteristic of the drug-polymer system and n is the 
release exponent indicating the type of drug release mechanism. The 
values n are obtained in the range of 0.557-0.693 indicating that the 
drug release mechanism followed Non-Fickian type of diffusion 
process. These results, along with correlation coefficients ‘r2’are 
presented in Table.2. A similar observation was reported by E. 
Yilmaz et al., [49] from the Preparation and characterization of pH-
sensitive semi-interpenetrating network hybrid hydrogels with 
sodium humate and kaolin. 
 
Table 2: Drug release rate constant and correlation coefficient of all formulations after fitting drug release data into different 
mathematical models 
S. No. Sample Zero order First order Higuchi Korsmeyer-peppas 
k0 r2 k1 r2 kH r2 n r2 
1 F1 8.246 0.934 1.971 0.974 20.59 0.988 0.693 0.988 
2 F2 7.847 0.957 1.975 0.985 20.64 0.992 0.679 0.990 
3 F3 6.455 0.966 1.984 0.991 21.96 0.984 0.688 0.971 
4 F4 8.566 0.982 1.977 0.993 22.57 0.988 0.587 0.978 
5 F5 10.88 0.969 1.971 0.986 24.07 0.990 0.557 0.985 
6 F6 10.21 0.950 1.972 0.990 24.18 0.979 0.675 0.994 
7 F7 6.627 0.965 1.983 0.989 21.42 0.998 0.690 0.984 
8 F8 5.918 0.972 1.983 0.992 20.51 0.990 0.671 0.976 
9 F9 5.656 0.956 1.980 0.978 16.31 0.969 0.671 0.978 
10 F10 6.803 0.967 1.979 0.991 20.56 0.992 0.661 0.979 
 
CONCLUSION 
A simple ionotropic gelation method was used to fabricate D-PA 
loaded SA/GE/KA microbeads. Microbeads formation was confirmed 
by FTIR spectroscopy. X-RD reveals that the KA should be 
intercalated with the drug and also it confirms the molecular level 
dispersion of D-PA into microbeads. Scanning Electron Microscopy 
(SEM) studies reveal that the beads were in spherical shape with 
Reddy et al. 




some wrinkled depressions on the surface. The in vitro release study 
indicates the D-PA released in a controlled manner. The in vitro 
release kinetics was assessed by different empirical equations and 
the data supported a Non-Fickian diffusion mechanism. Based on the 
results, Kaolin intercalated microbeads are promising material for 
drug carrier in emerging drug delivery systems. 
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